ARCHIVES

FDA Requires Independent Confirmation of Disease Progression in Cooperative Group Trials; Seeks Documentation for Avastin in Breast Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 32 | September 15, 2006

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: ONS Biotherapy Phase II, Outcomes-Research Grant

August 3, 2001

Carcinogenesis Testing To Stay In NCI, But Control Will Go To New Group Headed By Rall

September 15, 1978

Roswell Park Researchers Advocate HPV Vaccination For Boys As Well As Girls

May 29, 2009

FDA Approves Arranon For Leukemia And Lymphoma

December 30, 2005

Senate Investigates Opioid Manufacturers, Requests Study of Impact of DEA Policies

May 11, 2012

NCI Initiatives: Two RFAs Planned In New Technologies for Molecular Biology

December 6, 1996